Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox (Mpox) Research' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Advances in the Understanding of Etiology (I)
-
1. Infection and autoimmunity: a two-way relationship
- Dr. Ricard Cervera
-
2. Autoimmunity and atherosclerosis
- Prof. Johan Frostegard
-
3. Endothelium and autoimmunity
- Prof. Pier Luigi Meroni
- Advances in the Understanding of Etiology (II)
-
4. Prolactin has a pathogenic role in systemic lupus erythematosus
- Prof. Luis Jara-Quezada
-
5. Sjögren's syndrome: current knowledge and future prospects
- Prof. Athanasios G. Tzioufas
-
6. Genetic and environmental triggers of autoimmune thyroid diseases
- Prof. Yaron Tomer
- Advances in Pathogenesis and Clinical Manifestation
-
8. Pathogenic mechanisms of autoantibodies: circulating and local antibodies that form immune complexes
- Dr. Luís Eduardo Coelho Andrade
-
9. Pathogenic mechanisms of autoantibodies: antibodies to intracellular and membrane-bound antigens
- Dr. Luís Eduardo Coelho Andrade
-
10. What causes primary biliary cholangitis?
- Dr. M. Eric Gershwin
-
11. Capillaroscopy in autoimmune rheumatic diseases
- Prof. Maurizio Cutolo
- Advances in Diagnostic Methodologies (I)
-
12. The past, present & future of ANA testing: history and challenges of ANA
- Prof. Marvin J. Fritzler
-
13. The past, present & future of ANA testing: changing bandwidth and future of ANA
- Prof. Marvin J. Fritzler
-
14. Diagnostic methods in autoimmunity
- Mr. Steven Binder
-
15. Systemic lupus erythematosus: novel aspects of pathogenesis and treatment 1
- Prof. Chaim Putterman
- Dr. Noa Schwartz
-
16. Systemic lupus erythematosus: novel aspects of pathogenesis and treatment 2
- Prof. Chaim Putterman
- Dr. Noa Schwartz
-
17. Novel aspects of systemic sclerosis
- Prof. Gabriele Valentini
- Advances in Diagnostic Methodologies (II)
-
18. An update on the multiple faces of celiac disease
- Prof. Aaron Lerner
-
19. Protective autoantibodies
- Prof. Elias Toubi
-
21. Rheumatic fever: a model of a post-infectious autoimmune disease
- Prof. Jorge Kalil
- Treatments of autoimmune diseases
-
22. Intravenous immunoglobulins: clinical evidence
- Prof. Shaye Kivity
- Latest Developments in the Field
-
23. Adjuvants and autoimmunity
- Dr. Eitan Israeli
-
24. Antiphospholipid syndrome (APS): from pathogenesis to treatment
- Prof. Roger Levy
-
25. Vitamin D and autoimmunity
- Dr. Shir Azrielant
-
26. Pregnancy in rheumatic diseases
- Prof. Pier Luigi Meroni
- Archived Lectures *These may not cover the latest advances in the field
-
27. Pathogenic mechanisms of autoantibodies
- Prof. Cees Kallenberg
-
28. B lymphocytes on the frontline of autoimmunity
- Prof. Pierre Youinou
-
29. Apoptotic cell clearance deficiency
- Prof. Martin Herrmann
-
30. Auto-antibodies as predictors of autoimmune disease
- Dr. Nicola Bizzaro
-
31. Innate immunity and natural autoantibodies
- Prof. Luc Mouthon
-
32. Accelerated atherosclerosis in autoimmune rheumatic disease
- Dr. Andrea Doria
-
33. Pregnancy in autoimmune rheumatic diseases
- Prof. Angela Tincani
-
36. Immunologic mechanisms in systemic lupus erythematosus
- Prof. Kok-Yong Fong
-
37. Osteoimmunology
- Prof. João Eurico Fonseca
- Ms. Joana Caetano-Lopes
-
38. ANCA-associated systemic vasculitides
- Prof. Loic Guillevin
-
39. The common origin for diverse autoimmune diseases
- Prof. Juan-Manuel Anaya
-
40. Anti-cytokine therapy in rheumatoid arthritis
- Prof. Piercarlo Sarzi-Puttini
-
41. Sjogren's syndrome: autoimmune epithelitis
- Prof. Haralampos Moutsopoulos
-
42. Vitamin D and autoimmunity
- Dr. Howard Amital
-
43. Intravenous immunoglobulins: myth and reality
- Prof. Zera Tellier
Printable Handouts
Navigable Slide Index
- Introduction
- Outline
- Apoptotic cell clearance deficiency
- Apoptotic and necrotic cell death
- Apoptotic cell death during development
- The balance of life and death
- Inducers of apoptosis
- Apoptosis vs. primary necrosis
- The sites of apoptosis
- Exposure during apoptosis of phosphatidylserine
- Exposure of phosphatidylserine on viable cells
- Oxidation of phosphatidylserine
- Cyt c as a catalyst for selective oxidation of PS
- Inflammatory molecules in activated cells
- Inflammatory molecules in early apoptotic cells
- Inflammatory molecules in late apoptotic cells
- Inflammatory molecules in necrotic cells
- Summary on inflammatory molecules in apoptosis
- Clearance of dying cells
- Communication network of apoptosis
- Apoptotic cell - immune reaction/tolerance
- Necrotic cell - immune reaction/tolerance
- PS molecules sequestered inside cells
- Phosphatidylserine recognized by several ligands
- Cells bleb in later phases of apoptosis
- Late apoptotic cells recognized by several ligands
- Abnormalities in adaptor molecules linked to SLE
- PS-receptor is nuclear protein
- Summary - the clearance of apoptotic cells
- Repulsion activity with CD31
- Putative model of phagocyte attraction
- iPLA-2 induces the release of LPC
- Model of caspase and iPLA-2
- Oxydative stress cause oxydation of phospholipids
- Anti-inflammatory effects of apoptotic cells
- Anti-inflammatory effect on monocytes with LPS
- AxV skews cytokine secretion
- Blocking clearance restores Ig response
- Balance of inflamation - bacteria and viruses
- Balance of inflamation - early apoptotic cells
- Balance of inflamation - late apoptotic cells
- Systemic lupus erythematosus
- Example of patient with SLE
- Twin studies of SLE
- SLE clinical characteristics
- SLE etiology
- SLE pathology
- Apoptotic cells accumulation in cultured PBMC
- Clearance of apoptotic cells is impaired in MoMa
- Diseases with accumulation of apoptotic cells
- Apoptotic cell accumulation in germinal centers
- Uningested apoptotic nuclei in germinal center
- Germinal center sections with SLE
- Impaired clearance of apoptotic nuclei in SLE (1)
- Impaired clearance of apoptotic nuclei in SLE (2)
- Immune fluorescence images by CFM
- Germinal center of normal healthy donor
- Germinal center during somatic mutations
- Apoptotic remnants accumulate in macrophages
- Clearance failure in SLE patients
- Summmary - AC accumulation in germinal centers
- Apoptotic trash as an antigen
- Phagocytic defect and anti-dsDNA autoAb
- Binding specificity of 33.C9 variants
- 33.C9 Ab and anti-dsDNA activity
- IgG autoAb gained DNA reactivity
- Apoptotic cells in skin of patients with CLE
- Apoptotic cells in skin with CLE after UV exposure
- Graph of accumulation of apoptotic cells
- Humoral factors help clear apoptotic cells
- Summary of humoral factors
- Low clearance in stem cell-derived phagocytes
- Stem cells show proliferation in vitro V15.3.05 (1)
- Stem cells show proliferation in vitro V15.3.05 (2)
- Reduced uptake of IgG-coated beads V9.03
- Summary of stem cells-derived phagocytes
- Animal models for clearance deficiency
- Gene targeted mice with SLE-like symptoms
- Low apoptotic cell clearance is an SLE risk factor
- Supporting institutions
- Acknowledgements
Topics Covered
- Anti-inflammatory and immunosuppressive effects of apoptotic cells
- Autoimmune disease and clearance of dying cells
- Clearance deficiency of apoptotic cells
- Germinal centre tingible body macrophage deficiency
- Model for the generation of nuclear autoimmunity
- Annexin V as adjuvans for irradiated tumor cells
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Herrmann, M. (2007, October 1). Apoptotic cell clearance deficiency [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 14, 2024, from https://doi.org/10.69645/FGOL4148.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Martin Herrmann has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.